Answers are grounded in this paper and cite their sources.
Pharmaceutical solid-form development increasingly relies on data-driven and physics-informed models to anticipate crystal structures, polymorph landscapes, multicomponent forms, crystallization behavior, stability, and downstream developability, yet these tasks are often discussed together despite representing different prediction targets, evidence levels, and decision consequences. This systematic review evaluates how current methods connect molecular or process data to solid-state predictions
No takes yet. Share an insight, caveat, or question.
Keller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: